对于多发性硬化症相关的震,深度大脑刺激后的震和残疾结果
Samantha A Banks1, Matthew R Baker2, Eoin P Flanagan3
1Department of Neurology, Mayo Clinic, Rochester, MN, USA; Center for MS and Autoimmune Neurology, Mayo Clinic, Rochester, MN, USA.
概括
深度大脑刺激 (DBS) 为多发性硬化症 (MS) 患者的严重震提供了潜在的治疗方法,在没有疾病恶化的情况下显示出显著的震得分改善. 针对腹中介核 (VIM) 可能会优化结果.
科学领域:
- 神经学 神经学
- 神经外科 神经外科
- 医疗技术 医疗技术 医学技术
背景情况:
- 多发性硬化症 (MS) 的往往对药物治疗有抗性.
- 深度大脑刺激 (DBS) 提供了一个替代方案,但具有副作用和疾病恶化的风险.
研究的目的:
- 评估DBS在管理与MS相关的震方面的疗效和安全性.
- 评估DBS对MS患者残疾和震严重性的影响.
主要方法:
- 对18名经过DBS手术的MS-tremor患者进行了回顾性分析.
- 使用扩展残疾状态量表 (EDSS) 和Fahn-Tolosa-Marin (FTM) 震评分来衡量结果.
主要成果:
- 在患者中没有观察到术后复发或新的MRI病变.
- FTM震得分显示显著改善 (中位数为14.5到10,p=0.008).
- EDSS得分保持稳定 (中位数为6至6.25,p=0.2),EDSS为3.5-6.6的患者的结果可变.
结论:
- DBS是一种可行的治疗选择,用于严重的MS相关的震,而不会诱导疾病复发.
- 使用腹腔中间核 (VIM) 作为DBS的唯一目标可以增强震控制并保持MRI可访问性.
关键词:
残疾状况尺度 (EDSS) 是一个标准.多发性硬化症是多发性硬化症.深度大脑刺激 - - 深度大脑刺激,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,更多相关视频
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
9.3K
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
15.3K
相关概念视频
Parkinson's Disease: Treatment
970
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
970
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
